文献库，生知库 | 链接生命科学的每一步

System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support

针对有静脉血栓栓塞风险的住院患者的系统性血栓预防干预措施：聚焦跨平台临床决策支持

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm13072133

Tsaftaridis, Nikolaos; Goldin, Mark; Spyropoulos, Alex C

心血管

发表日期：2024

文献求助收藏

Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors

安德沙奈特α用于逆转口服直接Xa因子抑制剂患者严重出血的临床路径和结果

期刊:TH Open

影响因子:1.8

doi:10.1055/a-2306-0804

Goldin, Mark; Smith, Kolton; Koulas, Ioannis; Leung, Tungming; Ravi, Mayuri; Parhar, Sanjit; Shah, Sejal; Floyd, Kayla; Ohanesian, Lori; Bain, Rachel; Defonte, Daniella; Ochani, Kanta; Lin, Amanda; Patel, Bhumi; Tsaftaridis, Nikolaos; Jnani, Jack; Spyropoulos, Alex C

发表日期：2024

文献求助收藏

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

利伐沙班预防新冠肺炎门诊患者血栓事件、住院和死亡：一项随机临床试验

期刊:Circulation

影响因子:38.6

doi:10.1161/CIRCULATIONAHA.123.063901

Piazza, Gregory; Spyropoulos, Alex C; Hsia, Judith; Goldin, Mark; Towner, William J; Go, Alan S; Bull, Todd M; Weng, Stephen; Lipardi, Concetta; Barnathan, Elliot S; Bonaca, Marc P

Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry

合并心血管疾病的COVID-19住院患者出院后发生重大血栓栓塞和死亡的危险因素：来自CORE-19注册研究的启示

期刊:Thrombosis and Haemostasis

影响因子:4.3

doi:10.1055/a-2087-3003

Giannis, Dimitrios; Goldin, Mark; Rahman, Husneara; Sison, Cristina P; Lesser, Martin L; Ngu, Sam; Tsang, James; Qiu, Michael; Sanghani, Shreya; Yeh, Jackson; Matsagkas, Miltiadis; Arnaoutoglou, Eleni; Spyropoulos, Alex C

Universal EHRs Clinical Decision Support for Thromboprophylaxis in Medical Inpatients: A Cluster Randomized Trial

通用电子病历在内科住院患者血栓预防临床决策支持中的应用：一项整群随机试验

期刊:JACC Advances

影响因子:

doi:10.1016/j.jacadv.2023.100597

Spyropoulos, Alex C; Goldin, Mark; Koulas, Ioannis; Solomon, Jeffrey; Qiu, Michael; Ngu, Sam; Smith, Kolton; Leung, Tungming; Ochani, Kanta; Malik, Fatima; Cohen, Stuart L; Giannis, Dimitrios; Khan, Sundas; McGinn, Thomas

心血管

发表日期：2023

文献求助收藏

Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH

关于COVID-19抗血栓治疗的良好实践指南：国际血栓与止血学会（ISTH）科学标准委员会（SSC）的指导意见

期刊:Journal of Thrombosis and Haemostasis

影响因子:5

doi:10.1111/jth.15809

Spyropoulos, Alex C; Connors, Jean M; Douketis, James D; Goldin, Mark; Hunt, Beverley J; Kotila, Taiwo R; Lopes, Renato D; Schulman, Sam

心血管

发表日期：2022

文献求助收藏

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

利伐沙班联合阿司匹林用于急性重症内科患者的长期血栓预防：来自 MARINER 试验的启示

期刊:TH Open

影响因子:1.8

doi:10.1055/s-0042-1750379

Spyropoulos, Alex C; Goldin, Mark; Ageno, Walter; Albers, Gregory W; Elliott, C Gregory; Hiatt, William R; Halperin, Jonathan L; Maynard, Gregory; Steg, P Gabriel; Weitz, Jeffrey I; Spiro, Theodore E; Lu, Wentao; Marsigliano, Jessica; Raskob, Gary E; Barnathan, Elliot S

心血管

发表日期：2022

文献求助收藏

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review

补体介导的微血管损伤和血栓形成在重症 COVID-19 发病机制中的作用：综述

期刊:

影响因子:

doi:10.5493/wjem.v12.i4.53

Gianni, Panagiota; Goldin, Mark; Ngu, Sam; Zafeiropoulos, Stefanos; Geropoulos, Georgios; Giannis, Dimitrios

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

治疗剂量肝素与标准预防剂量或中等剂量肝素在COVID-19高危住院患者血栓预防中的疗效和安全性比较：HEP-COVID随机临床试验

期刊:Jama Internal Medicine

影响因子:23.3

doi:10.1001/jamainternmed.2021.6203

Spyropoulos, Alex C; Goldin, Mark; Giannis, Dimitrios; Diab, Wassim; Wang, Janice; Khanijo, Sameer; Mignatti, Andrea; Gianos, Eugenia; Cohen, Marc; Sharifova, Gulru; Lund, Jeet M; Tafur, Alfonso; Lewis, Paul A; Cohoon, Kevin P; Rahman, Husneara; Sison, Cristina P; Lesser, Martin L; Ochani, Kanta; Agrawal, Nirav; Hsia, Judith; Anderson, Victoria E; Bonaca, Marc; Halperin, Jonathan L; Weitz, Jeffrey I

心血管

发表日期：2021

文献求助收藏

Reversal of Direct Oral Anticoagulants (DOACs) for Critical Bleeding or Urgent Procedures

逆转直接口服抗凝剂（DOAC）用于危重出血或紧急手术

System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support

针对有静脉血栓栓塞风险的住院患者的系统性血栓预防干预措施：聚焦跨平台临床决策支持

Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors

安德沙奈特α用于逆转口服直接Xa因子抑制剂患者严重出血的临床路径和结果

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

利伐沙班预防新冠肺炎门诊患者血栓事件、住院和死亡：一项随机临床试验

Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry

合并心血管疾病的COVID-19住院患者出院后发生重大血栓栓塞和死亡的危险因素：来自CORE-19注册研究的启示

Universal EHRs Clinical Decision Support for Thromboprophylaxis in Medical Inpatients: A Cluster Randomized Trial

通用电子病历在内科住院患者血栓预防临床决策支持中的应用：一项整群随机试验

Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH

关于COVID-19抗血栓治疗的良好实践指南：国际血栓与止血学会（ISTH）科学标准委员会（SSC）的指导意见

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

利伐沙班联合阿司匹林用于急性重症内科患者的长期血栓预防：来自 MARINER 试验的启示

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review

补体介导的微血管损伤和血栓形成在重症 COVID-19 发病机制中的作用：综述

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

治疗剂量肝素与标准预防剂量或中等剂量肝素在COVID-19高危住院患者血栓预防中的疗效和安全性比较：HEP-COVID随机临床试验